The Infection Control Today® COVID-19 page brings readers the latest information and clinical updates on the coronavirus disease 2019 pandemic, from case counts and hospitalization rates to data on effective treatments for severe disease and the circulating viral variants.
March 15th 2024
Four years ago today, March 15, 2020, the COVID-19 lockdown began, and since then, the world has undergone significant changes. It has been a terrifying experience for everyone, especially for the infection prevention community, both within and outside of the health care sector. However, a crucial question remains unanswered: What has the infection prevention community learned from this pandemic, and where does it go from here?
Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?
View More
Understanding RSV: What You Need to Know to Prevent and Treat Respiratory Syncytial Virus in Your Patients
View More
Respiratory Syncytial Virus: Understanding the Infection Burden and Anticipating the Impact of Vaccines
View More
Medical Crossfire®: Which Patients with Hematologic Malignancies are at Risk for Secondary Immunodeficiency (SID)… and How Can We Leverage Evidence to Improve Their Outcomes?
View More
Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations
View More
CSL's ARCT-154: The World’s First Self-Amplifying mRNA Vaccine Approved for COVID-19 in Adults
February 1st 2024CSL achieves a global milestone as Japan approves ARCT-154, the first sa-mRNA COVID-19 vaccine, showcasing CSL's commitment to innovation, efficacy, and prolonged protection against variants. Jonathan Edelman, MD, senior VP of CSL Vaccine’s Innovation Unit, speaks with ICT.
Nurturing the Spirit: A Look Into the Well-Being of Infection Preventionists
January 19th 2024In the dynamic realm of infection prevention, professionals face both the potential for impactful contributions and the risk of burnout. The delicate balance between the highs and lows prompts an exploration into factors influencing the well-being of infection preventionists.
Differences in Attitudes Toward COVID-19 and Influenza Vaccines Revealed by Hesitancy Trends
January 3rd 2024Survey shows people think the influenza vaccine is safer than the COVID-19 vaccine. This is concerning as COVID-19 is more prevalent and hospitalizes more people. This could result in low vaccine uptake.
COVID-19 vs Seasonal Influenza: A Comparative Analysis Reveals Alarming Trends
January 2nd 2024Results of a study by Yan Xie and colleagues highlight the severe impact of COVID-19, with higher death rates, increased risks of long-term complications, and greater infectivity compared to seasonal influenza.
Ensuring Safe Journeys: Infection Prevention in Public Transportation
December 27th 2023While public transportation offers convenience and accessibility, it is crucial to remain mindful of the potential presence of germs, emphasizing the importance of adopting infection prevention measures during travel times.
Study Highlights Need to Strengthen Infection Prevention Measures Among Health Care Professionals
December 11th 2023A recent study in the American Journal of Infection Control reveals errors in infection prevention adherence among health care professionals during the COVID-19 pandemic, emphasizing the importance of improved training.
About the Infection Control Today's Educator of the Year Award
November 24th 2023Infection Control Today® is honored to announce it is reviving the Infection Control Today’s Educator of the Year Award™. For more information, please listen to Linda Spaulding, RN, CIC, the 2023 Winner of the Infection Control Today’s Educator of the Year Award.
Hot Topics in IPC: Influenza, COVID-19, and Mechanical Ventilation and Drug-Resistant Pathogens
November 3rd 2023In this Hot Topics in IPC, Saskia v. Popescu, PhD, MPH, MA, CIC, FAPIC, discusses her concerns about COVID-19 and influenza for this winter, and mechanical ventilation and drug-resistant pathogens.